Multi-chamber Expandable Therapeutic Agent Delivery Device

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current medical devices for delivering therapeutic agents to body lumens, such as drug eluting balloons and direct injection catheters, face challenges in effectively targeting and retaining agents within specific regions, leading to inefficiencies and potential harm due to agent dilution and uneven distribution.

Innovation Solution

A multi-chamber expandable therapeutic agent delivery device that simultaneously excludes blood from the target vessel and delivers therapeutic agents directly to the interior wall, using a compliant material structure with echogenic features for enhanced visibility and adjustable chamber configurations to optimize agent distribution.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If drug eluting balloons are used to deliver therapeutic agents, then the agents can be delivered to the target site, but the agents may be lost during positioning and require complex release mechanisms

Engineering Contradiction:
Improvetherapeutic agent delivery reliabilityVSAvoidrelease mechanism complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The device divides the delivery system into separate functional chambers: an inflation chamber for balloon expansion and therapeutic agent chambers for drug delivery. This segmentation allows independent control of balloon positioning and agent release, eliminating the need for complex integrated release mechanisms while ensuring reliable agent delivery.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces a fluid communication system as an intermediary between the therapeutic agent reservoir and the balloon surface. The agent is delivered through controlled fluid flow rather than direct contact or complex mechanical release, simplifying the delivery mechanism while maintaining reliability.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If direct injection catheters are used to inject active agents into blood vessels, then the agents can be delivered, but the agents may be diluted and unevenly distributed in the targeted region

Engineering Contradiction:
Improvetherapeutic agent delivery efficiencyVSAvoidagent distribution uniformity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The device incorporates multiple therapeutic agent chambers with individual delivery apertures distributed across different regions of the balloon surface. This allows localized delivery of agents to specific areas of the vessel wall, ensuring uniform distribution across the treatment zone while maximizing delivery efficiency.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent transitions from single-point injection to multi-point surface delivery by distributing therapeutic agent chambers across the two-dimensional balloon surface. This dimensional expansion ensures comprehensive coverage and uniform agent distribution across the entire targeted vessel region.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Reliability

If expandable balloons are used to retain injected active agent in targeted region, then agent retention is improved, but the device structure becomes more complex

Engineering Contradiction:
Improveagent retention capabilityVSAvoidballoon structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The device merges the retention function into the basic balloon structure itself. The expandable balloon creates a physical barrier that naturally retains agents in the targeted region without requiring additional complex retention mechanisms. The balloon's expansion geometry provides inherent agent containment.

Inventive Principle:
Principle #5Merging (Combining)

4Measurement precision

If multiple chambers are used for simultaneous blood exclusion and agent delivery, then treatment precision is improved, but the device complexity increases

Engineering Contradiction:
Improvetargeting precisionVSAvoidchamber configuration complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The device segments functionality into distinct chambers: an inflation chamber for blood exclusion and separate therapeutic agent chambers for targeted drug delivery. This segmentation enables precise independent control of each function while maintaining relatively simple overall device structure through modular design.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentEP3110490B1Multiple chamber, expandable therapeutic agent delivery device
Publication Date: 2021.05.12 MIRIZZI MICHAEL S
  • EP3110490B1 patent drawingFigure 1A
  • EP3110490B1 patent drawingFigure 1B~1F
  • EP3110490B1 patent drawingFigure 2

AI summary

A device having multiple chambers may be configured to expand to contact a substantial section of an interior wall of a body structure or lumen in order to simultaneously exclude blood or other liquid from a target structure while providing for delivery of a therapeutic agent directly to the interior wall. The expandable device may be manufactured from a plurality of flat sheets of material heat sealed to one another to form an inflation chamber and one, two or more delivery chambers. The sheets may also be bonded to an elongate catheter body having inflation and delivery lumens. The excluding of blood flow and delivery of therapeutic agents are completed by the same device.